Table 2.
Risk factors for HBeAg positivity
N | Odds ratio univariable analysis | p-value | Odds ratio multivariable analysis | p-value | |
---|---|---|---|---|---|
Sex | 391 | ||||
Female | 170 | 1 | 0.61 | ||
Male | 221 | 1.12 (0.71–1.78) | |||
Age | 391 | 0.98 (0.97–0.99) | 0.04 | 0.98 (0.96–0.99) | 0.02 |
Genotype | 391 | ||||
A | 67 | 1 | 1 | ||
B | 31 | 0.96 (0.38–2.45) | 0.93 | 0.79 (0.23–2.65) | 0.70 |
C | 36 | 2.63 (1.14–6.07) | 0.02 | 1.99 (0.67–5.91) | 0.22 |
D | 222 | 0.77 (0.42–1.42) | 0.41 | 1.57 (0.70–3.54) | 0.28 |
E | 28 | 0.94 (0.36–2.49) | 0.90 | 1.37 (0.35–5.35) | 0.64 |
F | 7 | 3.13 (0.64–15.30) | 0.16 | 4.11 (0.73–23.10) | 0.11 |
Region of origin | 391 | ||||
Switzerland | 63 | 1 | 1 | ||
Europe and Mediterranean | 161 | 0.34 (0.18–0.66) | 0.01 | 0.24 (0.10–0.57) | 0.01 |
Sub-Saharan Africa | 39 | 0.64 (0.27–1.51) | 0.31 | 0.42 (0.11–1.53) | 0.19 |
Asia | 89 | 1.27 (0.66–2.45) | 0.48 | 1.03 (0.41–2.58) | 0.94 |
Unknown and Other | 39 | 0.81 (0.35–1.88) | 0.63 | 0.53 (0.20–1.40) | 0.20 |
HIV Status | 228 | 0.03 | 0.11 | ||
HIV positive | 15 | 4.51 (1.45–14.01) | 2.53 (0.82–7.84) |
95 % Conf. Interval in brackets; HIV Human Immunodeficiency virus